SimonMed Imaging has introduced an updated brand and launched SimonMed Longevity, a new division centered on AI-enabled preventive care and longevity screening. The initiative marks what the company described as the next phase of its evolution as a national diagnostic imaging provider, expanding emphasis beyond traditional diagnostics to include earlier risk identification and preventive support powered by artificial intelligence.
SimonMed said SimonMed Longevity will offer whole-body MRI and enhanced, multi-modality screening aimed at people seeking a more proactive approach to long-term health. The company plans to start longevity services at 30 locations nationwide and expand availability to more than 70 sites by the end of the first quarter of 2026.
The company described the offering as a tiered portfolio of preventive MRI screening packages powered exclusively by 3T MRI technology, AI-enabled imaging protocols, and interpretation by its nationwide team of board-certified radiologists. SimonMed said the division builds on simonONE, its existing whole-body MRI program, and that the longevity launch integrates those offerings more directly into the SimonMed brand. During a transition period, simonONE will remain available at select locations.
SimonMed also cited its scale as a platform for expansion, noting that it has delivered more than 40 million scans nationwide. The company said the rebrand and longevity division are intended to broaden access to proactive screening and support healthier outcomes over time.
KEY QUOTES:
“For more than 20 years, SimonMed has focused on helping people get affordable access to the most advanced imaging technology. Today, those same technologies allow us not only to diagnose and treat disease earlier, but to identify risk sooner and help patients prevent, or delay onset, of many conditions.”
“Bringing Longevity under SimonMed allows us to scale preventive care more effectively and deliver a more seamless experience for patients and providers. Preventive imaging shouldn’t be a standalone offering—it should be part of routine healthcare.”
Dr. John Simon, Founder and CEO, SimonMed
“This evolution isn’t about changing who we are. It’s about building on our expertise in response to what patients are asking for—a clearer understanding of their health, and what to do about it, so they can live healthier, longer lives.”
Jenna Lloyd, Chief Marketing Officer, SimonMed
